Biofarm, one of the most important drug producers in Romania, estimates a 16% increase in turnover for this year, after recording a value of 239 million lei and an EBITDA of approximately 2021 in 2021 82 million lei, and for 2022 it aims to increase it by 15% compared to the end of the year.
If you want to read the entire content, you
need a subscription to Nine O’Clock
This content is for subscriber members only.
Subscribe now
Only 59 euros / month or 400 euros / year (VAT not included)
Get access to:
120.000 articles in 32 years of Nine O`Clock
600 new articles every month
No ads experience on the website
Do you already have an subscriber account? Enter in your account here: Login
The diplomatic daily newspaper Nine O’Clock does not assume responsibility for the information received and published on the public website. The responsibility for the content lies solely with the issuer of the press release. The diplomatic daily newspaper Nine O’Clock cannot be held accountable for false information transmitted by the…
If you want to read the entire content, you
need a subscription to Nine O’Clock
This content is for subscriber members only.
Subscribe now
Only 59 euros / month or 400 euros / year (VAT not included)
Get access to:
120.000 articles in 32 years of Nine O`Clock
600 new articles every month
No ads experience on the website
Do you already have an subscriber account? Enter in your account here: Login
